Xuling Luo
Impact in
- Pharmacology top 10%
- Apelin-related biomedical research
-
- Nuclear Receptors and Signaling
Papers in
-
- Apelin-related biomedical research 7
-
- Nuclear Receptors and Signaling 4
- Co-authors
- Linxi Chen (8 shared papers)Zhen Huang (6 shared papers)Meiqing Liu (4 shared papers)Shifang Huang (4 shared papers)Hong Zhou (2 shared papers)Mingzhu Tang (4 shared papers)Lanfang Li (4 shared papers)Jiuchang Zhong (2 shared papers)
- Journals
- Journal of Cellular Physiology (5 papers)Clinical Rheumatology (1 paper)Acta Biochimica et Biophysica Sinica (1 paper)Pharmacological Research (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xuling Luo
15 papers receiving 505 citations
Peers
Comparison fields: 5 of 85
- Pharmacology 146
- Cellular and Molecular Neuroscience 72
- Geriatrics and Gerontology 12
- Clinical Biochemistry 24
- Surgery 111
Countries citing papers authored by Xuling Luo
This map shows the geographic impact of Xuling Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuling Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuling Luo more than expected).
Fields of papers citing papers by Xuling Luo
This network shows the impact of papers produced by Xuling Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuling Luo. The network helps show where Xuling Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuling Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 118 | |
| 2 | 2019 | 98 | |
| 3 | 2018 | 51 | |
| 4 | 2021 | 42 | |
| 5 | 2017 | 38 | |
| 6 | 2018 | 37 | |
| 7 | 2020 | 31 | |
| 8 | 2022 | 28 | |
| 9 | 2020 | 19 | |
| 10 | 2019 | 15 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 9 | |
| 13 | 2023 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2018 | 4 |
About Xuling Luo
Xuling Luo is a scholar working on Pharmacology, Cellular and Molecular Neuroscience, Rheumatology, Surgery and Cell Biology, having authored 15 papers that have together received 510 indexed citations. Recurring topics across this work include Apelin-related biomedical research (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers), Nuclear Receptors and Signaling (4 papers), Lipid metabolism and disorders (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Autophagy in Disease and Therapy (3 papers), Mitochondrial Function and Pathology (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Pharmacology (146 citations), Cellular and Molecular Neuroscience (72 citations), Geriatrics and Gerontology (12 citations), Clinical Biochemistry (24 citations) and Surgery (111 citations). Xuling Luo has collaborated with scholars based in China and United States. Frequent co-authors include Linxi Chen, Zhen Huang, Meiqing Liu, Shifang Huang, Hong Zhou, Mingzhu Tang, Lanfang Li, Jiuchang Zhong, Jian‐Xiong Chen and Nian Fu. Their work appears in journals such as Journal of Cellular Physiology, Clinical Rheumatology, Acta Biochimica et Biophysica Sinica, Pharmacological Research and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.